Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Olanzapine - Important Safety Information from Eli Lilly as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
08/03/2004
Problem Or Issue:
Please find attached Safety Communiction from Eli Lilly in respect of Olanzapine and Risk of Mortality and Stroke in Elderly Patients with Dementia-Related Psychosis and/or Behavioural Disturbances
« Back
Date Printed: 28/03/2024